vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and SYPRIS SOLUTIONS INC (SYPR). Click either name above to swap in a different company.

PETMED EXPRESS INC is the larger business by last-quarter revenue ($40.7M vs $30.3M, roughly 1.3× SYPRIS SOLUTIONS INC). SYPRIS SOLUTIONS INC runs the higher net margin — -12.9% vs -26.0%, a 13.1% gap on every dollar of revenue. On growth, SYPRIS SOLUTIONS INC posted the faster year-over-year revenue change (-9.5% vs -23.3%). SYPRIS SOLUTIONS INC produced more free cash flow last quarter ($-1.5M vs $-9.2M). Over the past eight quarters, SYPRIS SOLUTIONS INC's revenue compounded faster (-7.7% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Sypris Solutions Inc. is a U.S.-headquartered provider of highly engineered components and specialized technical services, primarily serving aerospace, defense, automotive and commercial industrial markets. It delivers custom manufacturing, performance testing, and value-added engineering support for mission-critical systems and parts for global enterprise clients.

PETS vs SYPR — Head-to-Head

Bigger by revenue
PETS
PETS
1.3× larger
PETS
$40.7M
$30.3M
SYPR
Growing faster (revenue YoY)
SYPR
SYPR
+13.8% gap
SYPR
-9.5%
-23.3%
PETS
Higher net margin
SYPR
SYPR
13.1% more per $
SYPR
-12.9%
-26.0%
PETS
More free cash flow
SYPR
SYPR
$7.7M more FCF
SYPR
$-1.5M
$-9.2M
PETS
Faster 2-yr revenue CAGR
SYPR
SYPR
Annualised
SYPR
-7.7%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PETS
PETS
SYPR
SYPR
Revenue
$40.7M
$30.3M
Net Profit
$-10.6M
$-3.9M
Gross Margin
23.3%
4.6%
Operating Margin
-25.7%
-10.9%
Net Margin
-26.0%
-12.9%
Revenue YoY
-23.3%
-9.5%
Net Profit YoY
-1392.6%
-2992.6%
EPS (diluted)
$-0.50
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
SYPR
SYPR
Q4 25
$40.7M
$30.3M
Q3 25
$44.4M
$28.7M
Q2 25
$51.2M
$31.4M
Q1 25
$50.8M
$29.5M
Q4 24
$52.0M
$33.4M
Q3 24
$58.0M
$35.7M
Q2 24
$66.2M
$35.5M
Q1 24
$65.1M
$35.6M
Net Profit
PETS
PETS
SYPR
SYPR
Q4 25
$-10.6M
$-3.9M
Q3 25
$-8.5M
$517.0K
Q2 25
$-34.2M
$-2.1M
Q1 25
$-11.6M
$-899.0K
Q4 24
$-707.0K
$135.0K
Q3 24
$2.3M
$390.0K
Q2 24
$3.8M
$16.0K
Q1 24
$-5.0M
$-2.2M
Gross Margin
PETS
PETS
SYPR
SYPR
Q4 25
23.3%
4.6%
Q3 25
28.0%
7.2%
Q2 25
28.1%
8.2%
Q1 25
29.9%
11.4%
Q4 24
31.0%
16.1%
Q3 24
32.3%
16.8%
Q2 24
28.8%
15.9%
Q1 24
29.3%
8.1%
Operating Margin
PETS
PETS
SYPR
SYPR
Q4 25
-25.7%
-10.9%
Q3 25
-18.9%
-6.1%
Q2 25
-66.7%
-4.6%
Q1 25
-11.9%
-0.4%
Q4 24
-0.9%
3.9%
Q3 24
1.0%
4.8%
Q2 24
6.6%
3.6%
Q1 24
-5.9%
-3.9%
Net Margin
PETS
PETS
SYPR
SYPR
Q4 25
-26.0%
-12.9%
Q3 25
-19.2%
1.8%
Q2 25
-66.7%
-6.5%
Q1 25
-22.9%
-3.0%
Q4 24
-1.4%
0.4%
Q3 24
4.0%
1.1%
Q2 24
5.7%
0.0%
Q1 24
-7.7%
-6.2%
EPS (diluted)
PETS
PETS
SYPR
SYPR
Q4 25
$-0.50
$-0.17
Q3 25
$-0.41
$0.02
Q2 25
$-1.65
$-0.09
Q1 25
$-0.56
$-0.04
Q4 24
$-0.03
$0.00
Q3 24
$0.11
$0.02
Q2 24
$0.18
$0.00
Q1 24
$-0.24
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
SYPR
SYPR
Cash + ST InvestmentsLiquidity on hand
$26.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$32.8M
$17.8M
Total Assets
$88.0M
$107.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
SYPR
SYPR
Q4 25
$26.9M
Q3 25
$36.1M
Q2 25
$41.1M
Q1 25
$54.7M
Q4 24
$50.1M
Q3 24
$52.0M
Q2 24
$46.0M
Q1 24
$55.3M
Stockholders' Equity
PETS
PETS
SYPR
SYPR
Q4 25
$32.8M
$17.8M
Q3 25
$43.1M
$20.0M
Q2 25
$51.5M
$18.7M
Q1 25
$85.1M
$19.0M
Q4 24
$96.2M
$19.6M
Q3 24
$96.4M
$18.2M
Q2 24
$93.5M
$19.0M
Q1 24
$96.7M
$20.8M
Total Assets
PETS
PETS
SYPR
SYPR
Q4 25
$88.0M
$107.8M
Q3 25
$100.3M
$112.5M
Q2 25
$109.8M
$105.8M
Q1 25
$148.7M
$110.2M
Q4 24
$144.8M
$119.4M
Q3 24
$146.0M
$121.6M
Q2 24
$152.7M
$124.2M
Q1 24
$169.9M
$129.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
SYPR
SYPR
Operating Cash FlowLast quarter
$-9.2M
$-1.1M
Free Cash FlowOCF − Capex
$-9.2M
$-1.5M
FCF MarginFCF / Revenue
-22.7%
-5.0%
Capex IntensityCapex / Revenue
0.1%
1.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M
$-6.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
SYPR
SYPR
Q4 25
$-9.2M
$-1.1M
Q3 25
$-2.2M
$-178.0K
Q2 25
$-12.3M
$1.1M
Q1 25
$7.0M
$-5.5M
Q4 24
$-1.2M
$2.3M
Q3 24
$7.4M
$-4.8M
Q2 24
$-8.5M
$6.2M
Q1 24
$7.1M
$-1.7M
Free Cash Flow
PETS
PETS
SYPR
SYPR
Q4 25
$-9.2M
$-1.5M
Q3 25
$-4.8M
$-390.0K
Q2 25
$-13.6M
$941.0K
Q1 25
$4.6M
$-5.5M
Q4 24
$-1.9M
$1.9M
Q3 24
$6.1M
$-4.9M
Q2 24
$-9.2M
$6.0M
Q1 24
$5.9M
$-2.0M
FCF Margin
PETS
PETS
SYPR
SYPR
Q4 25
-22.7%
-5.0%
Q3 25
-10.8%
-1.4%
Q2 25
-26.5%
3.0%
Q1 25
9.1%
-18.8%
Q4 24
-3.7%
5.7%
Q3 24
10.6%
-13.8%
Q2 24
-13.9%
16.8%
Q1 24
9.0%
-5.7%
Capex Intensity
PETS
PETS
SYPR
SYPR
Q4 25
0.1%
1.3%
Q3 25
5.9%
0.7%
Q2 25
2.5%
0.5%
Q1 25
4.7%
0.0%
Q4 24
1.5%
1.2%
Q3 24
2.2%
0.4%
Q2 24
1.0%
0.5%
Q1 24
1.9%
0.9%
Cash Conversion
PETS
PETS
SYPR
SYPR
Q4 25
Q3 25
-0.34×
Q2 25
Q1 25
Q4 24
17.13×
Q3 24
3.18×
-12.21×
Q2 24
-2.27×
385.25×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

SYPR
SYPR

Sypris Electronics$17.7M59%
Transferred At Point In Time$12.5M41%

Related Comparisons